If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFenner PLC Regulatory News (FENR)

  • There is currently no data for FENR

AGM Trading Update

14 Jan 2015 07:00

RNS Number : 0822C
Fenner PLC
14 January 2015
 



14 January 2015

 

Fenner PLC

("Fenner" or "the Group")

 

AGM Trading Update

 

Overview

Trading in the period since 11th November 2014 has been characterised by a good performance by the AEP Division and an increasingly challenging environment in the ECS Division. In response to these conditions and the anticipated impact of the fall in oil prices on demand for oil and gas products within AEP, we have further increased our focus on margin control across the Group. Whilst seeking to ensure that the Group preserves its flexibility to respond to any recovery in its markets, cost reduction programmes have been implemented or accelerated and selected capital projects have been deferred across the Group.

AEP

Trading in the AEP division overall has been in line with expectations during the period, continuing the trend of improving performance reported in the second half of last year. The recent, precipitous fall in oil prices is expected to affect demand levels in those AEP businesses directly involved in the oil and gas industry from early in calendar year 2015. The non-oil, speciality polymer businesses in AEP, which represent approximately two-thirds of divisional turnover, are expected to continue to perform in line with expectations. Notwithstanding satisfactory current activity levels in the oil and gas related businesses, cost bases are being reduced in advance of the expected reduction in demand levels arising from oil prices, which are now widely expected to remain at or around current levels. These pre-emptive cost reductions are being carefully targeted to ensure that we retain our ability to continue to develop the business effectively.

ECS

Against a continuing backdrop of global mineral oversupply and correspondingly low commodity prices, any recovery in our ECS markets continues to be deferred. Demand levels in the Americas are stable, albeit at low levels, anticipated growth in EMEA has not been achieved and margins continue to decline in Australia as a result of customer-driven price pressures. In response to these circumstances, additional cost reductions are now being implemented in all territories to further protect trading margins. With only minimal near-term capital investment required in our ECS facilities, which have been well-invested through the programmes of the past decade, cash conversion is expected to be strong.

Outlook

Our balance sheet is strong, with borrowings remaining in line with expectations. We will complete the major project to consolidate our medical manufacturing facilities in the USA, which is vital to allow continuing strategic growth. Other capital programmes for 2015 are being curtailed to include only essential or near-term payback projects. In addition, future major projects have been deferred pending improved market conditions, which is currently expected to result in significantly lower capital expenditure in 2016 than previously indicated.

In addition to ongoing programmes to aggressively manage variable costs, these new management actions will reduce the run rate of cash overhead expenditure across the group by an incremental £9m on an annualised basis.

Recognising the anticipated effect of lower oil prices and the challenging trading conditions in ECS, offset by cost reductions across the Group, we now anticipate 2015 full year earnings to be slightly below our previous range of expectations. In addition, an exceptional charge will arise from implementation of the cost savings initiated during this year. Our actions leave the group well positioned to take advantage of recovery when it occurs.

 

Analyst and Investor conference call

A conference call for analysts and investors will be held at 8:30 a.m. (UK time) today to discuss this statement. Participants can join the call on + 44 (0)20 3059 8125. A recording of this conference call will be available for 7 days on + 44 (0)121 260 4861 using the access code 0090801 followed by #.

Forward-looking statements

Certain statements contained in this statement constitute forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors which may cause the actual results, performance or achievements of Fenner, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such statements.

 

For further information please contact:

Fenner PLC

Nicholas Hobson, Chief Executive OfficerRichard Perry, Group Finance Director

today: 020 7067 0700thereafter: 01482 626501

Weber Shandwick Financial

Nick Oborne / Tom Jenkins

020 7067 0700

 

Notes to editors:

Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance-critical applications. The Group operates through two divisions:

Engineered Conveyor Solutions: the ECS division, trading under the Fenner Dunlop, Fenner and Dunlop brand names, is a recognised leader in the global conveying market. The division offers a unique, comprehensive suite of products and services, which serve the conveying needs of mining, power generation and bulk handling markets.

Advanced Engineered Products: the AEP division uses advanced polymeric materials and technical expertise to provide high value-added solutions to customers' most challenging engineering problems. Customers are spread across a variety of end-user segments, including oil & gas and medical which account for some 40 per cent of divisional revenue, together with construction, transportation, automation and general industrial. AEP's trading names are recognised globally and include CDI Energy Products, EGC Critical Components, Hallite, AIP Precision Machining, Fenner Precision, Fenner Drives, James Dawson, Mandals, Secant Medical and Xeridiem.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUQUGUPAGBW
Date   Source Headline
8th Oct 20094:24 pmRNSHolding(s) in Company
5th Oct 20094:51 pmRNSNotice of Results
7th Sep 20097:00 amRNSPre-Close Trading Update
2nd Sep 200910:34 amRNSBlocklisting Interim Review
1st Sep 200910:38 amRNSDirector/PDMR Shareholding
10th Aug 20094:16 pmRNSHolding(s) in Company
17th Jul 20092:34 pmRNSHolding(s) in Company
17th Jul 20097:00 amRNSInterim Management Statement
22nd Jun 20099:16 amRNSHolding(s) in Company
19th Jun 20093:54 pmRNSHolding(s) in Company
9th Jun 20099:48 amRNSHolding(s) in Company
3rd Jun 20099:17 amRNSHolding(s) in Company
29th Apr 20097:00 amRNSHalf Year Results
14th Apr 200910:10 amRNSNotice of Results
1st Apr 20094:24 pmRNSHolding(s) in Company
26th Mar 20099:16 amRNSHolding(s) in Company
20th Mar 20099:05 amRNSHolding(s) in Company
12th Mar 20097:00 amRNSPre-Close Trading Update
5th Mar 20099:54 amRNSBlocklisting Interim Review
5th Feb 200912:53 pmRNSHolding(s) in Company
5th Feb 20099:36 amRNSHolding(s) in Company
28th Jan 20099:29 amRNSHolding(s) in Company
20th Jan 20099:59 amRNSHolding(s) in Company
14th Jan 200910:30 amRNSAGM and IMS
8th Jan 20092:59 pmRNSAnnual Information Update
2nd Jan 20099:56 amRNSHolding(s) in Company
24th Dec 200812:40 pmRNSSecond Price Monitoring Extn
24th Dec 200812:35 pmRNSPrice Monitoring Extension
23rd Dec 20089:21 amRNSHolding(s) in Company
22nd Dec 20089:46 amRNSHolding(s) in Company
12th Dec 20082:15 pmRNSHolding(s) in Company
11th Dec 20084:01 pmRNSNotice of AGM
8th Dec 20083:23 pmRNSDirector/PDMR Shareholding
3rd Dec 20089:21 amRNSDirector/PDMR Shareholding
24th Nov 200811:53 amRNSDirector/PDMR Shareholding
24th Nov 200811:47 amRNSDirector/PDMR Shareholding
21st Nov 200810:33 amRNSDirector/PDMR Shareholding
20th Nov 20082:59 pmRNSHolding(s) in Company
19th Nov 200810:21 amRNSDirector/PDMR Shareholding
14th Nov 20084:29 pmRNSDirector/PDMR Shareholding
14th Nov 200812:22 pmRNSDirector/PDMR Shareholding
14th Nov 200812:16 pmRNSDirector/PDMR Shareholding
14th Nov 200812:09 pmRNSDirector/PDMR Shareholding
14th Nov 200812:01 pmRNSDirector/PDMR Shareholding
13th Nov 20084:48 pmRNSDirector/PDMR Shareholding
13th Nov 200812:53 pmRNSDirector/PDMR Shareholding
13th Nov 200812:43 pmRNSDirector/PDMR Shareholding
13th Nov 200812:38 pmRNSDirector/PDMR Shareholding
12th Nov 20087:00 amRNSFinal Results
21st Oct 200812:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.